A study to evaluate the efficacy of selected homoeopathic medicines in the treatment of COVID-19 as an adjuvant therapy.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/02/040028
- Lead Sponsor
- Directorate of AYUSH Govt of NCT of Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mild, moderate cases laboratory confirmed cases of COVID-19.
Willing to give oral/ written informed consent
Subjects of age > 18years
Exclusion Criteria
Patients with severe/ critical disease will be excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Outcome in Relation to Impact on Daily Living (ORIDL) scale, which ranges fromââ?¬â??4 to +4, will be used for patient assessment at each follow-upTimepoint: Baseline, 1week, 2 week
- Secondary Outcome Measures
Name Time Method Change in the Symptom severity. <br/ ><br>Average duration until disease recovery after testing positive/day of appearance of symptoms.Timepoint: 7days